Paul D Leeson

Molecular Property Design: Does Everyone Get It?

Paul D Leeson, Robert J Young, P. Leeson, 2015, ACS medicinal chemistry letters.

Validity of ligand efficiency metrics.

Nicola J. Richmond, Andrew L Hopkins, Paul D Leeson, 2014, ACS medicinal chemistry letters.

Drug-like properties: guiding principles for design - or chemical prejudice?

John Steele, Paul D Leeson, Andrew M Davis, 2004, Drug discovery today. Technologies.

Time-related differences in the physical property profiles of oral drugs.

Paul D Leeson, Andrew M Davis, P. Leeson, 2004, Journal of medicinal chemistry.

Lessons learned from candidate drug attrition.

Paul D Leeson, P. Leeson, J. Empfield, 2010, IDrugs : the investigational drugs journal.

The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).

Glen Andrews, Paul D Leeson, Anders Åberg, 2011, Bioorganic & medicinal chemistry letters.

Molecular inflation, attrition and the rule of five.

Paul D Leeson, P. Leeson, 2016, Advanced drug delivery reviews.

Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules.

Niklas Blomberg, Britt-Marie Swahn, Paul D Leeson, 2011, Bioorganic & medicinal chemistry letters.